Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -0.90% |
| 2024 | 60.78% |
| 2023 | 35.81% |
| 2022 | 41.46% |
| 2021 | 128.37% |
| 2020 | 33.28% |
| 2019 | 0.00% |